A popular drug used to treat erectile dysfunction and symptoms of an enlarged prostate may increase the risk of a serious eye disease that can lead to blindness. Tadalafil, the active ingredient in ...

Candy B, Jones L, Williams R, et al. Phosphodiesterase type 5 inhibitors in the management of erectile dysfunction secondary to treatments for prostate cancer: findings from a Cochrane systematic ...

Results from a phase 3 clinical trial, recently published in The Lancet Oncology, present a significant breakthrough in the field of prostate cancer surgery. The NeuroSAFE technique, a novel approach ...

A landmark UK trial is investigating if energy waves can boost men's sex lives after prostate cancer surgery, the Express can ...

Researchers have identified 12 DNA sequences that may help doctors determine which men will suffer from erectile dysfunction (ED) following radiation therapy for prostate cancer. Identifying these ...

An erectile dysfunction drug that is also used to treat symptoms, such as sudden urgency and frequency, associated with an enlarged prostate in men may heighten the risk of glaucoma, a serious eye ...

The NeuroSAFE technique significantly improves erectile function outcomes post-prostatectomy, nearly doubling the number of patients with no or mild erectile dysfunction. Intraoperative tissue ...

Learn how Kegels work for men, improve bladder control, strengthen pelvic floor muscles and support recovery after prostate ...

Tadalafil users were 22% more likely to develop glaucoma, a study found, raising new questions about long-term Cialis use and eye pressure risks.

A prostate cancer diagnosis can be devastating. It brings us face-to-face with our mortality. Even knowing the high survival rates may not limit the worry and grief. While surgery can remove a tumor, ...